Research ExplorerPublicationsAspirin-exacerbated respiratory disease: Update on medical m...

Aspirin-exacerbated respiratory disease: Update on medical management

Standard

Aspirin-exacerbated respiratory disease: Update on medical management. / White, Andrew A; Woessner, Katharine; Simon, Ronald.

In: World journal of otorhinolaryngology - head and neck surgery, Vol. 6, No. 4, 12.2020, p. 241-247.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

White, AA, Woessner, K & Simon, R 2020, 'Aspirin-exacerbated respiratory disease: Update on medical management', World journal of otorhinolaryngology - head and neck surgery, vol. 6, no. 4, pp. 241-247. https://doi.org/10.1016/j.wjorl.2020.07.009

APA

White, A. A., Woessner, K., & Simon, R. (2020). Aspirin-exacerbated respiratory disease: Update on medical management. World journal of otorhinolaryngology - head and neck surgery, 6(4), 241-247. https://doi.org/10.1016/j.wjorl.2020.07.009

Vancouver

White AA, Woessner K, Simon R. Aspirin-exacerbated respiratory disease: Update on medical management. World journal of otorhinolaryngology - head and neck surgery. 2020 Dec;6(4):241-247. https://doi.org/10.1016/j.wjorl.2020.07.009

Bibtex

@article{30f34f6a80344eda86d231b5b91789f4,
title = "Aspirin-exacerbated respiratory disease: Update on medical management",
abstract = "Aspirin-exacerbated respiratory disease (AERD) is frequently diagnosed in patients with severe type 2 airway inflammation presenting with nasal polyps and severe asthma. It has been associated with a recalcitrant course with high medical and surgical requirements. The advent of recent biological and other targeted treatments show promise in the medical management of patient with AERD. The goal of complete disease control where patients no longer require recurrent surgical procedures, systemic corticosteroid exposure and may live with a stable and relatively normal quality of life is now within reach. Further work is necessary to identify biomarkers predictive of treatment response.",
author = "White, {Andrew A} and Katharine Woessner and Ronald Simon",
note = "{\textcopyright} 2020 The Authors.",
year = "2020",
month = dec,
doi = "10.1016/j.wjorl.2020.07.009",
language = "English",
volume = "6",
pages = "241--247",
journal = "World journal of otorhinolaryngology - head and neck surgery",
issn = "2095-8811",
publisher = "KeAi Communications Co.",
number = "4",

}

RIS

TY - JOUR

T1 - Aspirin-exacerbated respiratory disease: Update on medical management

AU - White, Andrew A

AU - Woessner, Katharine

AU - Simon, Ronald

N1 - © 2020 The Authors.

PY - 2020/12

Y1 - 2020/12

N2 - Aspirin-exacerbated respiratory disease (AERD) is frequently diagnosed in patients with severe type 2 airway inflammation presenting with nasal polyps and severe asthma. It has been associated with a recalcitrant course with high medical and surgical requirements. The advent of recent biological and other targeted treatments show promise in the medical management of patient with AERD. The goal of complete disease control where patients no longer require recurrent surgical procedures, systemic corticosteroid exposure and may live with a stable and relatively normal quality of life is now within reach. Further work is necessary to identify biomarkers predictive of treatment response.

AB - Aspirin-exacerbated respiratory disease (AERD) is frequently diagnosed in patients with severe type 2 airway inflammation presenting with nasal polyps and severe asthma. It has been associated with a recalcitrant course with high medical and surgical requirements. The advent of recent biological and other targeted treatments show promise in the medical management of patient with AERD. The goal of complete disease control where patients no longer require recurrent surgical procedures, systemic corticosteroid exposure and may live with a stable and relatively normal quality of life is now within reach. Further work is necessary to identify biomarkers predictive of treatment response.

U2 - 10.1016/j.wjorl.2020.07.009

DO - 10.1016/j.wjorl.2020.07.009

M3 - SCORING: Review article

C2 - 33336180

VL - 6

SP - 241

EP - 247

JO - World journal of otorhinolaryngology - head and neck surgery

JF - World journal of otorhinolaryngology - head and neck surgery

SN - 2095-8811

IS - 4

ER -